SG11201912651WA - New salt of n-(2,6-diethylphenyl)-8-({4-[4-(dimethylamino)piperidin-1-yl]-2-methoxyphenyl}am ino)-1-methyl-4,5-dihydro-1h-pyrazolo[4,3-h]quinazoline-3-carboxamide, its preparation and formulations containing it - Google Patents
New salt of n-(2,6-diethylphenyl)-8-({4-[4-(dimethylamino)piperidin-1-yl]-2-methoxyphenyl}am ino)-1-methyl-4,5-dihydro-1h-pyrazolo[4,3-h]quinazoline-3-carboxamide, its preparation and formulations containing itInfo
- Publication number
- SG11201912651WA SG11201912651WA SG11201912651WA SG11201912651WA SG11201912651WA SG 11201912651W A SG11201912651W A SG 11201912651WA SG 11201912651W A SG11201912651W A SG 11201912651WA SG 11201912651W A SG11201912651W A SG 11201912651WA SG 11201912651W A SG11201912651W A SG 11201912651WA
- Authority
- SG
- Singapore
- Prior art keywords
- diethylphenyl
- ino
- pyrazolo
- quinazoline
- piperidin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Inorganic Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17305826 | 2017-06-29 | ||
| PCT/EP2018/067394 WO2019002454A1 (en) | 2017-06-29 | 2018-06-28 | NOVEL N- (2,6-DIETHYLPHENYL) -8 - ({4- [4- (DIMETHYLAMINO) PIPERIDIN-1-YL] -2-METHOXYPHENYL} AMINO) -1-METHYL-4,5-DIHYDRO-1H SALT -PYRAZOLO [4,3-H] QUINAZOLINE-3-CARBOXAMIDE, ITS PREPARATION AND FORMULATIONS CONTAINING THE SAME |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201912651WA true SG11201912651WA (en) | 2020-01-30 |
Family
ID=59313166
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201912651WA SG11201912651WA (en) | 2017-06-29 | 2018-06-28 | New salt of n-(2,6-diethylphenyl)-8-({4-[4-(dimethylamino)piperidin-1-yl]-2-methoxyphenyl}am ino)-1-methyl-4,5-dihydro-1h-pyrazolo[4,3-h]quinazoline-3-carboxamide, its preparation and formulations containing it |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US11160806B2 (ko) |
| EP (1) | EP3645535B1 (ko) |
| JP (1) | JP7141416B2 (ko) |
| KR (1) | KR102609333B1 (ko) |
| CN (1) | CN110896636B (ko) |
| AR (1) | AR112040A1 (ko) |
| AU (1) | AU2018293729B9 (ko) |
| BR (1) | BR112019027924A2 (ko) |
| CA (1) | CA3068357C (ko) |
| CL (1) | CL2019003848A1 (ko) |
| EA (1) | EA039764B1 (ko) |
| ES (1) | ES2900048T3 (ko) |
| IL (1) | IL271628B2 (ko) |
| MA (1) | MA49498A (ko) |
| PL (1) | PL3645535T3 (ko) |
| SG (1) | SG11201912651WA (ko) |
| TW (1) | TWI750393B (ko) |
| UY (1) | UY37778A (ko) |
| WO (1) | WO2019002454A1 (ko) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2303891T3 (en) | 2008-06-26 | 2016-05-30 | Servier Lab | PYRAZOLO-quinazolines as modulators of protein kinase-ACTIVITY |
-
2018
- 2018-06-21 UY UY0001037778A patent/UY37778A/es unknown
- 2018-06-28 SG SG11201912651WA patent/SG11201912651WA/en unknown
- 2018-06-28 JP JP2019572116A patent/JP7141416B2/ja active Active
- 2018-06-28 KR KR1020207002339A patent/KR102609333B1/ko active IP Right Grant
- 2018-06-28 PL PL18732820T patent/PL3645535T3/pl unknown
- 2018-06-28 US US16/624,488 patent/US11160806B2/en active Active
- 2018-06-28 WO PCT/EP2018/067394 patent/WO2019002454A1/en unknown
- 2018-06-28 EP EP18732820.8A patent/EP3645535B1/en active Active
- 2018-06-28 CN CN201880043442.0A patent/CN110896636B/zh active Active
- 2018-06-28 ES ES18732820T patent/ES2900048T3/es active Active
- 2018-06-28 EA EA202090115A patent/EA039764B1/ru unknown
- 2018-06-28 AR ARP180101781A patent/AR112040A1/es unknown
- 2018-06-28 AU AU2018293729A patent/AU2018293729B9/en active Active
- 2018-06-28 TW TW107122235A patent/TWI750393B/zh active
- 2018-06-28 MA MA049498A patent/MA49498A/fr unknown
- 2018-06-28 BR BR112019027924-5A patent/BR112019027924A2/pt unknown
- 2018-06-28 CA CA3068357A patent/CA3068357C/en active Active
-
2019
- 2019-12-22 IL IL271628A patent/IL271628B2/en unknown
- 2019-12-26 CL CL2019003848A patent/CL2019003848A1/es unknown
-
2021
- 2021-09-30 US US17/490,318 patent/US20220016122A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US11160806B2 (en) | 2021-11-02 |
| CL2019003848A1 (es) | 2020-07-10 |
| KR20200020905A (ko) | 2020-02-26 |
| CN110896636B (zh) | 2022-07-19 |
| EA039764B1 (ru) | 2022-03-11 |
| IL271628B1 (en) | 2023-03-01 |
| BR112019027924A2 (pt) | 2020-08-18 |
| IL271628A (en) | 2020-02-27 |
| AR112040A1 (es) | 2019-09-11 |
| UY37778A (es) | 2019-01-31 |
| TWI750393B (zh) | 2021-12-21 |
| CN110896636A (zh) | 2020-03-20 |
| KR102609333B1 (ko) | 2023-12-01 |
| ES2900048T3 (es) | 2022-03-15 |
| US20220016122A1 (en) | 2022-01-20 |
| AU2018293729A1 (en) | 2020-01-23 |
| JP2020525477A (ja) | 2020-08-27 |
| AU2018293729B2 (en) | 2022-03-10 |
| AU2018293729B9 (en) | 2022-07-14 |
| EP3645535B1 (en) | 2021-09-08 |
| CA3068357A1 (en) | 2019-01-03 |
| EA202090115A1 (ru) | 2020-05-25 |
| MA49498A (fr) | 2021-05-26 |
| EP3645535A1 (en) | 2020-05-06 |
| PL3645535T3 (pl) | 2022-03-21 |
| WO2019002454A1 (en) | 2019-01-03 |
| US20200246339A1 (en) | 2020-08-06 |
| IL271628B2 (en) | 2023-07-01 |
| CA3068357C (en) | 2022-04-19 |
| TW201904971A (zh) | 2019-02-01 |
| JP7141416B2 (ja) | 2022-09-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL273852A (en) | Preparation and storage of liposomal RNA formulations suitable for treatment | |
| IL267210A (en) | Amino acid compounds and methods for treating muscle diseases and disorders | |
| IL261996A (en) | A new RNA structure and methods for using it to improve the therapeutic effects of cytotoxic cells and stem cells | |
| WO2016065028A8 (en) | Crystalline forms of 5-chloro-n4-[-2-(dimethylphosphoryl) phenyl]-n2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl) piperidin-1-yl] pyrimidine-2,4-diamine | |
| MX2015012414A (es) | Sal de omecamtiv mecarbilo y proceso para preparar la sal. | |
| HK1247203A1 (zh) | 取代的咪唑並[1，2-α]吡啶-2-基胺化合物及其藥物組合物和使用方法 | |
| IL274578A (en) | Pharmaceutical compounds and preparations thereof for use in the treatment of leiftic diseases | |
| IL289763A (en) | Compounds, pharmaceutical compounds and methods for preparing compounds and their use | |
| HK1246656A1 (zh) | 含有伊立替康的口服固體製劑及其製備方法 | |
| FI3697784T5 (fi) | Imidatso[4,5-b]pyridiiniyhdisteet ja niiden farmaseuttiset koostu- mukset tulehduksellisten häiriöiden hoitoa varten | |
| IL276430A (en) | A pharmaceutical compound, its cures, its formulations, and methods for its preparation and use | |
| HK1214600A1 (zh) | 種含磷吡啶並 嘧啶- -酮類化合物或其藥學上可接受的鹽、藥物組合物及其應用 | |
| EP4073049A4 (en) | NEW CRYSTALLINE FORMS OF FLUFENACET, METHOD FOR THEIR PRODUCTION AND THEIR USE | |
| IL272495A (en) | Pharmaceutical compounds and preparations thereof for use in the treatment of leiftic diseases | |
| WO2017075264A8 (en) | Dibenzo azepine compounds and their use in the treatment of otic diseases and disorders | |
| IL265153A (en) | 8-(azetidin-1-yl)-[4,2,1]triazolo[5,1-a]pyridinyl compounds, preparations and methods of use | |
| IL271628A (en) | A new salt of N-(6,2-diethylphenyl)-8-({4-[4-(dimethylamino)piperidin-1-yl]-2-methoxyphenyl}amino)-1-methyl-5,4-dihydro-1H -pyrazolo[3,4-H]quinazoline-3-carboxamide, its preparation and formulations containing it | |
| PT3398946T (pt) | Sal de derivado de morfolina e a sua forma cristalina, bem como método de preparação, composição farmacêutica e a sua utilização | |
| EP4073050A4 (en) | NEW CRYSTALLINE FORMS OF FLUFERACET, ITS PREPARATION PROCESS AND ITS USE | |
| WO2016022700A3 (en) | Tlr-independent small molecule adjuvants | |
| EA201790795A1 (ru) | СОЕДИНЕНИЯ 4Н-ПИРИДО[1,2-a]ПИРИМИДИН-4-ОНА | |
| GB201718838D0 (en) | Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases | |
| GB201712742D0 (en) | Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases |